TCB
JAZZ icon

Thoma Cressey Bravo’s Jazz Pharmaceuticals JAZZ Stock Holding History

Thoma Cressey Bravo’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-357,230
Closed -$32.9M – 1
2013
Q3 		$32.9M Sell
357,230
-101,900
-22% -$8.22M 55.45% 1
2013
Q2 		$31.6M Buy
+459,130
New +$28.1M 54.05% 1

Other funds holding JAZZ

PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
WBC
Westpac Banking Corp Sydney, Australia $1.44B AUM 28.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Thoma Cressey Bravo's JAZZ Position: Q4 2013 in Review

Thoma Cressey Bravo sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2013, closing a stake of 357,230 shares — an estimated $32.9M sold.

Thoma Cressey Bravo first reported a position in JAZZ in Q2 2013 and held it in 2 quarters. The position peaked at $32.9M in Q3 2013. 280 funds tracked by Wall St. Rank hold JAZZ as of Q4 2013.

  • Thoma Cressey Bravo reported no remaining Jazz Pharmaceuticals position as of Q4 2013 after selling out during the quarter.
  • Thoma Cressey Bravo sold 357,230 Jazz Pharmaceuticals shares in Q4 2013, an estimated $32.9M.
  • Thoma Cressey Bravo first reported a position in Jazz Pharmaceuticals in Q2 2013 and held it in 2 quarters.
  • Thoma Cressey Bravo's Jazz Pharmaceuticals position peaked at $32.9M in Q3 2013.
  • 280 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2013.

Based on Thoma Cressey Bravo's 13F filing for Q4 2013.